Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Launay

Showing results (291-300 of 307) with videos related to

Pageof 31
Sort By:
RMD Open|December 10, 2024
Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysisAlexis F Guédon, Fabrice Carrat, Luc Mouthon, et al.
Rheumatology (Oxford, England)|September 10, 2015
Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective studyArsène Mekinian, Eric Grignano, Thorsten Braun, et al.
Respiratory Medicine and Research|December 24, 2022
2022 Update of indications and contraindications for lung transplantation in FranceJérôme Le Pavec, Christophe Pison, Sandrine Hirschi, et al.
RMD Open|March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueJoerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2023
Clinical and Prognostic Factors in Patients with IgG4-Related Kidney DiseaseAnis Chaba, Arnaud Devresse, Vincent Audard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersJulien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.
Pageof 31

Showing results (291-300 of 307) with videos related to

Sort By:
Pageof 31
RMD Open|December 10, 2024
Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysisAlexis F Guédon, Fabrice Carrat, Luc Mouthon, et al.
Rheumatology (Oxford, England)|September 10, 2015
Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective studyArsène Mekinian, Eric Grignano, Thorsten Braun, et al.
Respiratory Medicine and Research|December 24, 2022
2022 Update of indications and contraindications for lung transplantation in FranceJérôme Le Pavec, Christophe Pison, Sandrine Hirschi, et al.
RMD Open|March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueJoerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2023
Clinical and Prognostic Factors in Patients with IgG4-Related Kidney DiseaseAnis Chaba, Arnaud Devresse, Vincent Audard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersJulien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.
Pageof 31